Coenzyme Q10 and Migraine Relief

Research has shown that migraines are linked to inflammation.

A clinical trial examined Coenzyme Q10โ€™s (CoQ10โ€™s) effects on episodic migraines in women, finding significant reductions in migraine frequency, duration, severity. CoQ10 also reduced the levels of TNF-ษ‘ and CGRP, a peptide linked to migraines that promotes inflammation and pain signaling.

Aย meta-analysis of five studies concluded that CoQ10 supplementation is more effective than a placebo in reducing migraine occurrence and duration in both children and adults.

โ€œThe results support the use of CoQ10 as a potent therapeutic agent with respect to migraine duration and migraine days/month.โ€ (Zeng et al., 2018)

These findings were corroborated in a subsequent meta-analysis of six clinical trials that showed CoQ supplemented as a preventative measure was effective for reducing the duration and frequency of migraines.

Dr. Rebecca Crews profile picture

Dr. Rebecca Crews

Learn More

Leading the companyโ€™s engagement in transformative research. She is committed to scientific integrity in the health and wellness space and data transparency with consumers.

She holds a Ph.D. in Biochemical and Molecular Nutrition from Tufts University and has over ten years of nutrition science research experience, exploring various dimensions of human well-being in academic and government laboratories.